-31.0%
MRNA vs ALLE
+46.7%
-77.7%
-93.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | ALLE | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.3% | -0.9% | -1.5% |
| 7D | -12.7% | -4.4% | -8.3% | -10.5% |
| 30D | -20.7% | +15.5% | -36.1% | -27.8% |
| 3M | +46.3% | +13.9% | +32.3% | +33.6% |
| 6M | +305.2% | +43.2% | +262.1% | +225.1% |
| YTD | +561.2% | +16.6% | +544.6% | +487.6% |
| 1Y | +772.1% | +16.5% | +755.6% | +675.5% |
| 3Y | +147.0% | +80.3% | +66.7% | +66.2% |
| All | -31.0% | +46.7% | -77.7% | -53.9% |
Cumulative growth
Daily Returns
Daily percentage return beside ALLE.
Daily Out/Under-Performance
Portfolio return minus ALLE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ALLE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded ALLE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling